Bioburden Detection: The Hidden Bottleneck in Drug Manufacturing
Bioburden detection is one of the quality control measures required to ensure drug safety –…
Labiotech Reach works with Biopharma and Life Sciences companies to create impactful brand awareness campaigns that deliver clear and proven ROI.
Feel free to check our portfolio of sponsored articles below or visit Labiotech Reach for more details on how we work.
Bioburden detection is one of the quality control measures required to ensure drug safety –…
With over six million cases and 376,000 deaths globally, the coronavirus pandemic is unlike anything…
The relationship between biotechs and their CRO partners has been long in the making. These…
In 2019, the global contract development and manufacturing organizations (CDMO) market was valued at about…
The exact number of women suffering from endometriosis is unknown. However, it is estimated that…
By 2027, the global gene therapy market is estimated to reach a staggering value of…
The gene therapy market is booming. Viral vectors, the key delivery systems for gene therapies,…
By 2021, the global biologics market is expected to reach a value of $319B. But…
Today, we are continuing our interview series with Peter Homberg, Partner and Head of the…
By 2024, the gene therapy market is expected to reach an estimated worth of $13B…
The excitement about cell and gene therapies is almost tangible within the biotech and pharma…
Also known as 'mini-organs in a dish', organoids are defined as 3D structures that mimic…